Crowdonomics
WatchlistPortfolio
CB Therapeutics, Inc.

Reg CF · SAFE · Mar 2023

WithdrawnReg CFSAFE
via RepublicView campaign
Raised
$10.8K / $1.2M max
1% of ceiling
Investors
32
$337.5 avg
Valuation cap
$45M
cap, not an agreed valuation

Raised over time

Cumulative raisedInvestors
$12K$6K$0
43220
Mar 1, 2023 · openedApr 11, 2023 · last reading
Deadline Apr 30, 2023 — 19 days out

Left axis: cumulative dollars raised. Right axis: cumulative investors. Live figures via Republic; investor counts may lag the platform by up to a day.

Financials disclosed in this offering

FY2020–FY2021 · hover for source
$0
−$2.3M
FY2020
$2.0M
−$1.8M
FY2021
RevenueNet income
Metric
FY2020 reviewed*
FY2021 reviewed*
Income statement
Revenue
$0
$2,014,066
Cost of goods sold
$0
$0
Gross margin
—
100%
Net income
-$2,278,343
-$1,772,158
Taxes paid
$1,600
$3,017
Balance sheet
Cash
$13,453
$1,810,709
Accounts receivable
$0
$14,066
Total assets
$910,015
$3,722,376
Short-term debt
$677,795
$287,110
Long-term debt
$730,988
$188,555
Total liabilities
$1,408,783
$475,665
Other
Headcount
—
18

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Deal terms

Valuation cap$45M
Conversion discount20%

Offering details

Target$25,000
Max$1,235,000
Min investment$250
OpenedMar 1, 2023
DeadlineApr 30, 2023
ClosedApr 11, 2023
Days active41

Links & provenance

Campaign pageSEC filing
Source: Manual
0001949369-23-000001

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.